200 related articles for article (PubMed ID: 32505877)
21. Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa.
Fortuin-de Smidt MC; Singh-Moodley A; Badat R; Quan V; Kularatne R; Nana T; Lekalakala R; Govender NP; Perovic O;
Int J Infect Dis; 2015 Jan; 30():41-8. PubMed ID: 25448331
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study.
Smit J; López-Cortés LE; Kaasch AJ; Søgaard M; Thomsen RW; Schønheyder HC; Rodríguez-Baño J; Nielsen H
Clin Microbiol Infect; 2017 Jan; 23(1):27-32. PubMed ID: 27343816
[TBL] [Abstract][Full Text] [Related]
24. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
[TBL] [Abstract][Full Text] [Related]
25. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
[TBL] [Abstract][Full Text] [Related]
26. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
27. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
Kok J; O'Sullivan MV; Gilbert GL
J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
29. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
30. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
31. Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study.
López-Cortés LE; Gálvez-Acebal J; Del Toro MD; Velasco C; de Cueto M; Caballero FJ; Muniain MA; Pascual A; Rodríguez-Baño J
PLoS One; 2013; 8(12):e82958. PubMed ID: 24376617
[TBL] [Abstract][Full Text] [Related]
32. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene.
Eshwara VK; Munim F; Tellapragada C; Kamath A; Varma M; Lewis LE; Mukhopadhyay C
Int J Infect Dis; 2013 Nov; 17(11):e1051-5. PubMed ID: 23891294
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
Braquet P; Alla F; Cornu C; Goehringer F; Piroth L; Chirouze C; Revest M; Lechiche C; Duval X; Le Moing V;
Clin Microbiol Infect; 2016 Nov; 22(11):948.e1-948.e7. PubMed ID: 27515395
[TBL] [Abstract][Full Text] [Related]
35. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
Davis JS; Turnidge J; Tong S
Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
[TBL] [Abstract][Full Text] [Related]
36. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.
López-Cortés LE; Del Toro MD; Gálvez-Acebal J; Bereciartua-Bastarrica E; Fariñas MC; Sanz-Franco M; Natera C; Corzo JE; Lomas JM; Pasquau J; Del Arco A; Martínez MP; Romero A; Muniain MA; de Cueto M; Pascual A; Rodríguez-Baño J;
Clin Infect Dis; 2013 Nov; 57(9):1225-33. PubMed ID: 23929889
[TBL] [Abstract][Full Text] [Related]
37. Mortality in Staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: secondary analysis of a prospective cohort study.
Willekens R; Puig-Asensio M; Suanzes P; Fernández-Hidalgo N; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Pigrau C; Almirante B
J Infect; 2021 Dec; 83(6):656-663. PubMed ID: 34626700
[TBL] [Abstract][Full Text] [Related]
38. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
[TBL] [Abstract][Full Text] [Related]
39. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study.
Nguyen CT; Gandhi T; Chenoweth C; Lassiter J; Dela Pena J; Eschenauer G; Nagel JL
J Antimicrob Chemother; 2015 Dec; 70(12):3390-6. PubMed ID: 26338049
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
